Home » Topics » BioWorld Science

BioWorld Science
RSS

Tumor stem cells need much methionine

May 17, 2019

M.D. Anderson studies anti-PR1/HLA-A2 monoclonal antibody Hu8F4 in advanced hematologic malignancies

May 16, 2019

NCI studies whether Lixte's LB-100 can penetrate glioblastoma multiforme tumors

May 16, 2019

New TrpC6 antagonists discovered by Hydra Biosciences and Boehringer Ingelheim

May 16, 2019

Vernalis, Servier present Bcl-2 inhibitors

May 16, 2019

Phase I/II results of DNase eye drops for dry eye disease

May 16, 2019

Emory University synthesizes fusion peptides including uPA or EGFR sequences with a toxin

May 16, 2019

FDA clears IND for Turning Point's TPX-0022

May 16, 2019

FDA approves Venclexta with Gazyva for previously untreated CLL or SLL

May 16, 2019

New phase I trial studies MK-8558 in antiretroviral-naive patients with HIV-1

May 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 21, 2025.
ADPD 2025: Novel treatment modalities in neurodegenerative disorders
BioWorld Science
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...
Post-Pfizer dropout, Lilly Achieves GLP-1 win in phase III
BioWorld
Days after Pfizer Inc. pulled the plug on its oral GLP-1 candidate danuglipron, Eli Lilly and Co. aired positive top-line data from the phase III trial called...
Many US tariffs paused, pharma warned, EU put on notice
BioWorld
The on-again, off-again U.S. tariffs are off again, at least for now, for more than 75 countries that have reached out to the Trump administration to negotiate...